After cross-patient infection occurred with the Clinitron bed, we look
ed for a way to deliver an antibiotic agent into the inner environment
of the Clinitron bed through the filtering system in a manner that wo
uld sterilize the contaminated microspheres. Multiple cultures of the
contaminated microspheres from the Clinitron air-fluidized bed were do
ne, and the infecting microorganisms were identified. The appropriate
antibiotic powder was delivered through the filter system of the bed,
and the microspheres were recultured after treatment. After an antibio
tic powder was administered, the microspheres cultured were sterile. W
e found that the Clinitron bed can be safely, easily, and inexpensivel
y sterilized and reused by the administration of antibiotic agent thro
ugh the air filter system. Furthermore resistant bacteria can be treat
ed with antibiotic agent sparingly used in a clinical setting because
of toxicity.